Search clinical trials for: CU01-1001

Total 2936 results

Larimar Therapeutics, Inc.
Veristat, Inc.; Metrum Research Group, LLC

Completed

Single Ascending Dose Study of CTI-1601 Versus Placebo in Subjects With Friedreich's Ataxia

Friedreich Ataxia

United States
BioFirst Corporation

Completed

A Phase I Study of Vitargus® in Vitrectomy

Vitreo-retinal Surgery

Australia
Quark Pharmaceuticals

Completed

QPI-1002 for Prevention of Delayed Graft Function in Recipients of an Older Donor Kidney Transplant (ReGIFT)

Delayed Graft Function

United States, Spain, Canada, Australia, Netherlands, Germany, Belgium, France, Argentina, Brazil, Czechia
Charles University, Czech Republic
University Hospital Pilsen

Completed

SLNM in Endometrial Cancer Combined With OSNA (SLNM/OSNA)

Endometrial Cancer

Czechia
Catabasis Pharmaceuticals

Completed

A Multiple Ascending Dose Study of CAT-1004 in Patients With Type 2 Diabetes

Type 2 Diabetes

United States
MacuCLEAR, Inc.

Completed

A Pilot Study of the Safety of MC-1101 in Both Normal Volunteers and Patients With Early Dry AMD

Age-Related Macular Degeneration

United States
TRF Pharma, Inc

Terminated

TRF-1101 Assessment in Sickle Cell Disease

Sickle Cell Disease

United States
Zai Lab (Shanghai) Co., Ltd.

Completed

A Trial of ZL-1201 in Subjects With Advanced Cancer

Advanced Cancer

United States, China
Neurological Associates of West Los Angeles

Enrolling by invitation

Focused Ultrasound for the Treatment of ADHD Symptoms

ADHD

United States
Veralox Therapeutics

Completed

Phase I Study of VLX-1005 in Healthy Subjects

Safety and Tolerability in Healthy Volunteers

United States
Larimar Therapeutics, Inc.
Veristat, Inc.; Metrum Research Group, LLC

Completed

Multiple Ascending Dose Study of CTI-1601 Versus Placebo in Subjects With Friedreich's Ataxia

Friedreich Ataxia

United States
Respivant Sciences GmbH
Respivant Sciences Inc.

Terminated

A Phase 2b Study of Inhaled RVT-1601 for the Treatment of Persistent Cough in IPF (SCENIC)

Chronic Cough | IPF | Persistent Cough in IPF

United States, United Kingdom, Netherlands, Australia, Belgium, New Zealand, Turkey, Italy, Germany, Czechia, Canada
HeadSense Medical
University Medical Center Goettingen; Klinikum Darmstadt; Klinikum Stuttgart

Unknown

An Evaluation of a Non-invasive Brain Monitor

Brain Injuries | Brain Neoplasms | Subarachnoid Hemorrhage | Vasospasm, Intracranial | Hydrocephalus

Germany
Cyclerion Therapeutics

Completed

A Trial of IW-1701, A Stimulator of Soluble Guanylate Cyclase (sGC), in Healthy Subjects

Healthy

United States
Quark Pharmaceuticals

Completed

A Study to Evaluate Efficacy and Safety of QPI-1002 for Prevention of Acute Kidney Injury Following Cardiac Surgery

Acute Kidney Injury

United States, Canada, Germany
HeadSense Medical
Akron Children's Hospital

Withdrawn

Non-invasive Intracranial Pressure (ICP) Monitoring in Pediatric Patients

Intracranial Hypertension

United States
HeadSense Medical
Vanderbilt University Medical Center

Unknown

An Evaluation of HS-1000 Device Capabilities in the Diagnosis and Assessment of Patients After Concussion

Brain Injuries | Brain Concussion

United States
Mayo Clinic
National Institutes of Health (NIH)

Completed

Fat Gain and Cardiovascular Disease Mechanisms

Sleep Apnea Syndromes | Hypertension | Obesity

United States
Mallinckrodt

Withdrawn

IK-1001 (Sodium Sulfide (Na2S) for Injection) in Subjects With Acute ST-Segment Elevation Myocardial Infarction

ST-Segment Elevation Myocardial Infraction
Sound Pharmaceuticals, Incorporated
Medical University of South Carolina; Cystic Fibrosis Foundation

Enrolling by invitation

SPI-1005 for Prevention and Treatment of Tobramycin Induced Ototoxicity

Ototoxicity

United States
Fujifilm Pharmaceuticals U.S.A., Inc.

Completed

Study of FF-10101-01 in Patients With Relapsed or Refractory Acute Myeloid Leukemia

AML, Adult

United States
Idorsia Pharmaceuticals Ltd.

Completed

A Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Ascending Doses of ACT-1004-1239 in Healthy Male Subjects

Healthy

United States
Forest Laboratories

Completed

Study of Pancreatic Enzyme Product in Pediatric Participants With Cystic Fibrosis and Exocrine Pancreatic Insufficiency

Cystic Fibrosis | Exocrine Pancreatic Insufficiency

United States
Fujifilm Pharmaceuticals U.S.A., Inc.

Completed

Study of FF-10501-01 in Patients With Relapsed or Refractory Hematological Malignancies

AML | MDS | CMML

United States
TG Therapeutics, Inc.

Recruiting

Study to Evaluate Efficacy When Transitioning From a Current Disease Modifying Therapy (DMT) to Ublituximab (ENHANCE)

Relapsing Multiple Sclerosis

United States
Longevity Inc.

Completed

Proximod Pharmacokinetics in Healthy Subjects and Patients With Rheumatoid Arthritis

Rheumatoid Arthritis

China
Longevity Inc.

Completed

Proximod Pharmacokinetics In Healthy Subjects

Rheumatoid Arthritis

China
Centre for Probe Development and Commercialization
McDougall Scientific Ltd.

Completed

Safety and Efficacy of [18F]PSMA-1007 Injection in Suspected Persistent or Recurrent Prostate Cancer.

Recurrent Prostate Cancer | Prostate Cancer Recurrent

Canada
Oryzon Genomics S.A.

Completed

Study to Test the Efficacy and Safety of Vafidemstat in Adult Borderline Personality Disorder Population

Borderline Personality Disorder

Spain, Serbia, United States, Germany, Bulgaria
Staidson (Beijing) Biopharmaceuticals Co., Ltd

Completed

A Study of STSA-1002 in Healthy Subjects

Healthy Subject

China
Massachusetts General Hospital

Withdrawn

Focused Ultrasound Neuromodulation for Treatment of Temporal Lobe Epilepsy (LIFUP)

Low Intensity Ultrasound Pulsarions
Staidson Biopharma Inc.

Completed

The Safety and Tolerability of STSA-1005 Following Intravenous Infusion in Healthy Subjects

Healthy

United States
Catabasis Pharmaceuticals

Terminated

An Open-Label Extension Study of Edasalonexent in Boys With Duchenne Muscular Dystrophy (GalaxyDMD)

Duchenne Muscular Dystrophy

United States, Canada, Australia, United Kingdom, Germany, Sweden
Cyclerion Therapeutics

Completed

Trial of IW-1701 (A Stimulator of Soluble Guanylate Cyclase (sGC)) in Healthy Volunteers

Healthy

United States
John Villano

Withdrawn

NovoTTF-100A Therapy for Refractory CNS Involved Small Cell Lung Cancer

Small Cell Lung Cancer | Brain Metastasis

United States
Primo Biotechnology Co., Ltd
ABX advanced biochemical compounds GmbH

Recruiting

Diagnostic Performance of 18F-PSMA-1007 PET/CT in Suspected Prostate Cancer Patient

Prostate Cancer | Prostate Neoplasm

Taiwan
Suzhou Zanrong Pharma Limited

Recruiting

A Phase 1 Trial of ZN-A-1041 Enteric Capsules or Combination in Patients With HER2-Positive Advanced Solid Tumors

Advanced Solid Tumors | HER2-positive Breast Cancer

United States
Bolt Biotherapeutics, Inc.
Hoffmann-La Roche

Active, not recruiting

Trial of BDC-1001 +/- Pertuzumab in Subjects With HER2-Positive Metastatic Breast Cancer

Metastatic Breast Cancer | HER2-positive Breast Cancer

Spain, United States, Italy
Shenzhen Institute of Advanced Technology, Chinese...

Recruiting

Sources and Mechanisms of Energy Compensation

Exercise | Food Preferences | Energy Expenditure | Energy Intake

China
Hunazine Biotech S.L.

Recruiting

Assessment of a Novel Fixed-dose Combination (FDC) Drug VR-AD-1005 for the Treatment of Acute Watery Diarrhea in Cholera

Cholera

Bangladesh
Sichuan Baili Pharmaceutical Co., Ltd.

Recruiting

A Study of SI-B001+SI-B003± Chemotherapy in the Treatment of Locally Advanced or Metastatic Non-small Cell Lung Cancer

Non-small Cell Lung Cancer

China
University Medical Center Groningen
Stichting Hemato-Oncologie voor Volwassenen Nederland

Recruiting

Comparison of Point-of-care Produced CAR T-cell With Commercial CAR T-cells in Patients With R/R LBCL (HOVON161)

NHL | DLBCL - Diffuse Large B Cell Lymphoma

Netherlands
Staidson (Beijing) Biopharmaceuticals Co., Ltd

Completed

The Safety and Tolerability of STSA-1002 Following Intravenous Infusion in Healthy Subjects

Healthy

United States
Quark Pharmaceuticals

Terminated

QPI-1002 Phase 3 for Prevention of Major Adverse Kidney Events (MAKE) in Subjects at High Risk for AKI Following Cardiac Surgery

Cardiac Surgery

United States, Germany, Spain, Australia, Austria, Canada, New Zealand, United Kingdom, Belgium, Czechia, France
Global Alliance for TB Drug Development

Completed

Food Effect Study on the Bioavailability and PK of PA-824 Tablets in Healthy Adult Subjects (CL-003)

Tuberculosis

United States
Quark Pharmaceuticals

Completed

I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation

Delayed Graft Function | Other Complication of Kidney Transplant

United States, Spain, Germany, France, Canada
Catabasis Pharmaceuticals

Completed

Safety, Tolerability, and Pharmacokinetic Study of CAT-1004 in Healthy Adult Volunteers

Healthy

United States
Quark Pharmaceuticals

Terminated

A Dose Escalation and Safety Study of I5NP to Prevent Acute Kidney Injury (AKI) in Patients at High Risk of AKI Undergoing Major Cardiovascular Surgery (QRK.004)

Acute Kidney Injury | Acute Renal Failure

United States
Pharmacosmos A/S

Completed

Pharmacokinetic Study of Iron Isomaltoside 1000 Administered by 250 mg IV Bolus Injection or 500 mg Intravenous Infusion to Patients With Non-hematological Malignancies Associated With Chemotherapy Induced Anaemia (PK-CIA-06)

Patients With Chemotherapy Induced Anemia (CIA)

United States
University of California, Irvine

Completed

A Prospective Study of a New Device for Monitoring Cerebral Oxygenation on Healthy Volunteers

Cerebral Ischemia

United States

Search clinical trials for: CU01-1001

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Spain

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations